Mannitol, parenteral grade (low endotoxin) at Raleigh Drug Product: Auto-approved; 4 quotes; 1 attempt(s); checks 6/7; batches 27/27 feasible.
Auto-approved; 4 quotes; 1 attempt(s); checks 6/7; batches 27/27 feasible.
- Status
- completed
- Approval
- auto
- Transfer
- 302 from SITE-COR, ~7 days
- Purchase
- 280 from Kestrel Polyols (RFQ-118), 19 days + 7 days QC
- covers_need pass transfer 302 + purchase 280 = 582 vs need 582 kg
- lands_in_time pass 35 days available after transfer (cover 49.0 d − safety 14 d); chosen lead time 19 d + QC release 7 d = 26 d
- qualified_only pass Kestrel Polyols is released_for_use
- comparable_quotes pass 4 usable quotes of 4 received on RFQ-118
- batches_feasible pass 27/27 batches on LINE-RAL-AF1, LINE-RAL-LY1 have released material at start (transfer released day 9, purchase released day 26)
- grade_fit pass Kestrel Polyols: parenteral low-endotoxin vs aseptic fill at cleanroom grade A: parenteral, low-endotoxin, USP-NF + Ph. Eur.; lyophilization at cleanroom grade A: parenteral, low-endotoxin, USP-NF + Ph. Eur.; quality rank 3 of 4
- grounded fail recommended_supplier_id: SUP-006 / Recommendation: award to SUP-006 (Corrib Pharma Supply), quote Q-0252 — facts select SUP-004 (Kestrel Polyols), released_for_use; SUP-006 is not shown as released_for_use.; Only SUP-006 (Q-0252, 24.93 EUR/kg, 29.6596 USD/kg landed, 17,261.86 USD total) can land by the need-by date of 2026-10-17, via its 9-day expedited lead time — contradicted by facts: SUP-004 (19-day lead + 7-day QC = 26 days) lands within the 35 days available (lands_in_time pass).; The other three quotes do not meet the need-by date: SUP-004 (Q-0249, 21.8625 USD/kg, 19-day lead time, expedite not available) — contradicted; SUP-004 is the plan's released_for_use supplier and meets the need-by date.; three negotiations were already in an accepted state and the expedite could not be raised for them, while SUP-006's negotiator secured an expedite at no premium — negotiation outcomes not shown in the facts.